During the past decade, Stanford University School of Medicine (Falk Cardiovascular Research Center) conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Stanford University School of Medicine (Falk Cardiovascular Research Center)" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator, "Aldagen" with 1 trials as a collaborator and "Center for Cell and Gene Therapy, Baylor College of Medicine" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Stanford University School of Medicine (Falk Cardiovascular Research Center)" are "Aortic Dissection" (1 trials), "Arterial Occlusive Disease" (1 trials), "Intermittent Claudication" (1 trials), "Ischemia" (1 trials) and "Ischemic Cardiomyopathy" (1 trials). Many other conditions were trialed in "Stanford University School of Medicine (Falk Cardiovascular Research Center)" in a lesser frequency.

Most popular intervention types in "Stanford University School of Medicine (Falk Cardiovascular Research Center)" are "Biological" (2 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "ALD-301" (1 trials), "HGF plasmid" (1 trials), "Mesenchymal Stem Cells (MSC)" (1 trials), "Placebo (Plasmalyte A)" (1 trials) and "Placebo (vehicle)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Stanford University School of Medicine (Falk Cardiovascular Research Center)" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Stanford University School of Medicine (Falk Cardiovascular Research Center)". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Stanford University School of Medicine (Falk Cardiovascular Research Center), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Stanford University School of Medicine (Falk Cardiovascular Research Center), 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".